138 related articles for article (PubMed ID: 34846623)
1. The remarkably frequent use of EQ-5D in non-economic research.
Wang A; Rand K; Yang Z; Brooks R; Busschbach J
Eur J Health Econ; 2022 Aug; 23(6):1007-1014. PubMed ID: 34846623
[TBL] [Abstract][Full Text] [Related]
2. A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature.
Shaw C; Longworth L; Bennett B; McEntee-Richardson L; Shaw JW
Patient; 2024 May; 17(3):239-249. PubMed ID: 38085457
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments.
Zahirian Moghadam T; Powell J; Sharghi A; Zandian H
Cost Eff Resour Alloc; 2023 Nov; 21(1):81. PubMed ID: 37924060
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany.
Heinrich F; Cordts I; Günther R; Stolte B; Zeller D; Schröter C; Weyen U; Regensburger M; Wolf J; Schneider I; Hermann A; Metelmann M; Kohl Z; Linker RA; Koch JC; Radelfahr F; Schönfelder E; Gardt P; Mohajer-Peseschkian T; Osmanovic A; Klopstock T; Dorst J; Ludolph AC; Schöffski O; Boentert M; Hagenacker T; Deschauer M; Lingor P; Petri S; Schreiber-Katz O
J Neurol; 2023 Oct; 270(10):4922-4938. PubMed ID: 37356024
[TBL] [Abstract][Full Text] [Related]
5. Health economics research into supporting carers of people with dementia: a systematic review of outcome measures.
Jones C; Edwards RT; Hounsome B
Health Qual Life Outcomes; 2012 Nov; 10():142. PubMed ID: 23181515
[TBL] [Abstract][Full Text] [Related]
6. Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?
Devlin NJ; Pan T; Sculpher M; Jit M; Stolk E; Rowen D; van Hout B; Norman R
Pharmacoeconomics; 2023 Oct; 41(10):1165-1174. PubMed ID: 37439998
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of instruments for measuring outcomes in economic evaluation within aged care.
Bulamu NB; Kaambwa B; Ratcliffe J
Health Qual Life Outcomes; 2015 Nov; 13():179. PubMed ID: 26553129
[TBL] [Abstract][Full Text] [Related]
8. Health utility values of breast cancer treatments and the impact of varying quality of life assumptions on cost-effectiveness.
Kregting LM; Vrancken Peeters NJMC; Clarijs ME; Koppert LB; Korfage IJ; van Ravesteyn NT
Int J Cancer; 2024 Jul; 155(1):117-127. PubMed ID: 38478916
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study.
McManus E; Meacock R; Parkinson B; Sutton M
Appl Health Econ Health Policy; 2023 Nov; 21(6):891-903. PubMed ID: 37787972
[TBL] [Abstract][Full Text] [Related]
10. Measurement, modeling and QALYs.
Langley PC; McKenna SP
F1000Res; 2020; 9():1048. PubMed ID: 33093950
[TBL] [Abstract][Full Text] [Related]
11. A cost-utility study of elective haemorrhoidectomies in Canada.
Guo M; Karimuddin AA; Liu G; Crump T; Brown CJ; Raval MJ; Phang PT; Ghuman A; Mok J; Sutherland JM
Colorectal Dis; 2024 Mar; 26(3):527-533. PubMed ID: 38247259
[TBL] [Abstract][Full Text] [Related]
12. Capturing Patient Value in an Economic Evaluation.
Koster F; Kok MR; Lopes Barreto D; Weel-Koenders AEAM
Arthritis Care Res (Hoboken); 2024 Feb; 76(2):191-199. PubMed ID: 37667586
[TBL] [Abstract][Full Text] [Related]
13. Medical costs and quality-adjusted life years associated with smoking: a systematic review.
Feirman SP; Glasser AM; Teplitskaya L; Holtgrave DR; Abrams DB; Niaura RS; Villanti AC
BMC Public Health; 2016 Jul; 16():646. PubMed ID: 27460828
[TBL] [Abstract][Full Text] [Related]
14. Automatic assessment of socioeconomic impact on cardiac rehabilitation.
Calvo M; Subirats L; Ceccaroni L; Maroto JM; de Pablo C; Miralles F
Int J Environ Res Public Health; 2013 Oct; 10(11):5266-83. PubMed ID: 24284349
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life and healthcare consultations among adult patients before and after diagnosis with rheumatic heart disease in Namibia.
Shimanda PP; Söderberg S; Iipinge SN; Lindholm L; Shidhika FF; Norström F
BMC Cardiovasc Disord; 2023 Sep; 23(1):456. PubMed ID: 37704961
[TBL] [Abstract][Full Text] [Related]
16. Burden of disease associated with lower levels of income among US adults aged 65 and older.
Lubetkin EI; Jia H
BMJ Open; 2017 Jan; 7(1):e013720. PubMed ID: 28093436
[TBL] [Abstract][Full Text] [Related]
17. Impact of colonoscopy on health-related quality of life: findings from the RECEDE study.
Andronis L; Waugh N; Zanganeh M; Krishnamoorthy A; Parsons N; Hull M; Wheatstone P; Arasaradnam RP;
Health Qual Life Outcomes; 2024 Jun; 22(1):49. PubMed ID: 38926801
[TBL] [Abstract][Full Text] [Related]
18. Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER'S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor Symptoms.
Langley PC
Innov Pharm; 2023; 14(1):. PubMed ID: 38035319
[TBL] [Abstract][Full Text] [Related]
19. Methodological challenges surrounding QALY estimation for paediatric economic evaluation.
Petrou S
Cost Eff Resour Alloc; 2022 Mar; 20(1):10. PubMed ID: 35241102
[TBL] [Abstract][Full Text] [Related]
20. Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses.
Sanghera S; Walther A; Peters TJ; Coast J
Patient; 2022 Jul; 15(4):445-457. PubMed ID: 34854064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
